Pharmaceutical Analysis & Statistics in Europe Countries, July 2014

Talk to Louis

+1 718 618 4302

Search inside this page

Publishers

You might be interested in: therapeutics, drug, cancer, more »

1-50 of about 13 000 reports

Purchase Reports From Reputable Market Research Publishers

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

  • $ 22 464
  • Industry report
  • May 2014
  • by Global Research & Data Services

The expansion of the global vitamin and provitamin industry is forecast to reach 2.6% p.a. in the coming years. Between 2007 and 2013 the market increased with an average annual growth of 8.0%. Currently, ...

  • Industries : Vitamin and Supplement
  • Countries : United States, World, Europe, Asia, South America, North America, Czech Republic, South Korea, Philippines, Netherlands, Singapore, Panama, Slovenia, Slovakia (slovak Republic), Belgium, Japan, India, China, Australia, Argentina, United Kingdom, Macedonia, Lithuania, Sri Lanka, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Mexico, Canada, Ukraine, Sweden, Spain, Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt
PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Italy, Spain, France, Germany, United Kingdom, Europe, World
MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • May 2014
  • by Global Data

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...

  • Industries : Pathology
  • Countries : World, France, China, Italy, Japan, Brazil, Germany, India, Spain, United Kingdom, United States, Europe
Global Vitamin and Provitamin Market to 2018 - Market Size, Top 10 Countries, Trends, and Forecasts

Global Vitamin and Provitamin Market to 2018 - Market Size, Top 10 Countries, Trends, and Forecasts

  • $ 5 174
  • Industry report
  • May 2014
  • by Global Research & Data Services

This industry data report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for vitamins and provitamins in the world and in the top 10 global countries. ...

  • Industries : Vitamin and Supplement
  • Countries : South Korea, World, Argentina, United States, Singapore, Indonesia, Mexico, France, Japan, India, China, Asia
Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

  • $ 4 650
  • Industry report
  • May 2014
  • by MarketsandMarkets

The mold inhibitors market is expected to grow at a CAGR of 2.9% from 2014 to 2019. The estimation is made on the basis of the increasing health awareness among consumers as mold causes allergies, asthma, ...

  • Industries : Drug and Medication
  • Countries : World, North America, Europe, China, Mexico, Canada, India, South Africa, Brazil, France, Germany, Japan, United States
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
MarketVIEW: Group B Streptococcus

MarketVIEW: Group B Streptococcus

  • $ 4 495
  • Industry report
  • May 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Group B beta streptococci (GBS) or Streptococcus agalactiae is an encapsulated Gram-positive coccus capable of producing a range of diseases in humans of all age ranges. In the neonate, the bacterium can ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Africa, Brazil, Mexico, Canada, United Kingdom, Spain, Italy, France, Germany, Europe, North America
MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • May 2014
  • by Global Data

MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...

  • Industries : Pathology
  • Countries : France, Italy, Germany, Spain, United Kingdom, Europe
EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • July 2014
  • by Global Data

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023 Summary Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences ...

  • Industries : Pathology
  • Countries : Germany, World, United States, Spain, United Kingdom, Italy, France, Japan
EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • May 2014
  • by Global Data

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023 Summary Non-Hodgkin's lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body's immune ...

  • Industries : Pathology
  • Countries : United States, Germany, World, United Kingdom, Spain, Italy, France
EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • May 2014
  • by Global Data

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023 Summary Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood ...

  • Industries : Pathology
  • Countries : United States, France, World, Spain, Italy, Germany
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022

DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022

Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
About 8 700 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • Media Release
  • July 2014
    13 pages
  • Pathology  

    Cancer  

  • Europe  

    United States  

    Switzerland  

View report >

47 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Select Products Inc.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.